{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:09:23Z","timestamp":1790255363517,"version":"4.1.0"},"reference-count":87,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/501100000243","name":"W. Garfield Weston Foundation","doi-asserted-by":"publisher","award":["RR162076"],"award-info":[{"award-number":["RR162076"]}],"id":[{"id":"10.13039\/501100000243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Parkinson\u2019s Disease"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The aggregation and spread of \u03b1-synuclein within brain are associated with the loss of dopaminergic neurons and the formation of Lewy bodies as seen in Parkinson's disease. Blocking the initiation of \u03b1-synuclein aggregation, or the spread of such aggregates, may offer disease-modifying approaches to slow disease progression. Previous studies have demonstrated that modification of aggregation prone proteins, including \u03b1-synuclein, with O-linked \u03b2-\n                      <jats:italic toggle=\"yes\">N<\/jats:italic>\n                      -acetylglucosamine (O-GlcNAc) reduces their aggregation. Small molecule inhibitors of the enzyme O-GlcNAcase (OGA), which removes O-GlcNAc from proteins, confers neuroprotective benefits in various preclinical disease models of Alzheimer's and Parkinson's diseases.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study investigates the effects of long-term pharmacological enhancement of O-GlcNAcylation in a transgenic mouse model of Parkinson's disease overexpressing human \u03b1-synuclein.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Thiamet-G was orally administered to mThy1-hSNCA and wild-type (WT) mice for ten months. Behavioral assessments were conducted to examine changes in locomotion and cognition. Histological analyses were performed to analyze \u03b1-synuclein aggregates and dopaminergic neurons in brain sections. Immunoblot and ELISA analyses were performed to analyze O-GlcNAc and soluble \u03b1-synuclein using brain lysates, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Thiamet-G increased the level of O-GlcNAc in the brain of both mThy1-hSNCA and WT mice. The levels of total \u03b1-synuclein in the brain were unaltered. However, Thiamet-G strongly attenuated the deposition of pS129-immunoreactive \u03b1-synuclein aggregates within the substantia nigra, prior to observable neurodegeneration. Thiamet-G also protected against locomotor decline.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These results support OGA inhibition as a therapeutic approach to block the pathological formation of toxic \u03b1-synuclein as a disease-modifying treatment against Parkinson's disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/1877718x251410291","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:23:51Z","timestamp":1770747831000},"page":"217-232","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Pharmacological inhibition of O-GlcNAcase reduces pS129-\u03b1-synuclein positive aggregates in the substantia nigra of mThy1-hSNCA mice"],"prefix":"10.1177","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6641-1326","authenticated-orcid":false,"given":"Jefferey","family":"Yue","sequence":"first","affiliation":[{"name":"Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Psychology, Simon Fraser University, Burnaby, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3665-7296","authenticated-orcid":false,"given":"Kim H","family":"Tran","sequence":"additional","affiliation":[{"name":"Department of Psychology, Simon Fraser University, Burnaby, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7902-152X","authenticated-orcid":false,"given":"Matthew","family":"Deen","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Simon Fraser University, Burnaby, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1747-3600","authenticated-orcid":false,"given":"Viktor","family":"Holicek","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Simon Fraser University, Burnaby, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3408-9184","authenticated-orcid":false,"given":"Wai Hang","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6778-1505","authenticated-orcid":false,"given":"Mateusz","family":"Michalik","sequence":"additional","affiliation":[{"name":"Department of Psychology, Simon Fraser University, Burnaby, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Power","sequence":"additional","affiliation":[{"name":"Department of Psychology, Simon Fraser University, Burnaby, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7014-039X","authenticated-orcid":false,"given":"Cheryl L","family":"Wellington","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1709-4889","authenticated-orcid":false,"given":"Neil V","family":"Watson","sequence":"additional","affiliation":[{"name":"Department of Psychology, Simon Fraser University, Burnaby, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6897-5558","authenticated-orcid":false,"given":"David J","family":"Vocadlo","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada"},{"name":"Department of Chemistry, Simon Fraser University, Burnaby, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-018-0058-0"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-022-00410-y"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005072-199804000-00005"},{"key":"e_1_3_3_5_2","first-page":"879","article-title":"Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson\u2019s disease and dementia with Lewy bodies","volume":"152","author":"Baba M","year":"1998","unstructured":"Baba M, Nakajo S, Tu PH, et al. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson\u2019s disease and dementia with Lewy bodies. Am J Pathol 1998; 152: 879\u2013884.","journal-title":"Am J Pathol"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnen\/62.6.644"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncb748"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.131102"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M116.726752"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abd3207"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaa320"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1606899113"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-020-00978-4"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.105411"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1621367114"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2019.08.003"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2021.113646"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0084442"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-9-42"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awp099"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R114.601351"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-019-0512-1"},{"key":"e_1_3_3_23_2","first-page":"1778","article-title":"Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer\u2019s disease","volume":"47","author":"Mosconi L","year":"2006","unstructured":"Mosconi L, Sorbi S, de Leon MJ, et al. Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer\u2019s disease. J Nucl Med 2006; 47: 1778\u20131786.","journal-title":"J Nucl Med"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.96"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.797"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2013.11.025"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-017-0181-0"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells11050906"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M600933200"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.2337\/db08-0994"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M900268-MCP200"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1200425109"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/nchem.2361"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1808845116"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/febs.15349"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41589-024-01551-2"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2015.06.003"},{"key":"e_1_3_3_38_2","unstructured":"Buggia-Prevot V Schoepp D Braithwaite S et al. Targets to therapies: a new target de-risking initiative at MJFF https:\/\/zenodo.org\/records\/13989174 (2024 accessed 16 February 2025)."},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15119-w"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.10231"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-012-0104-2"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2008.02.014"},{"key":"e_1_3_3_43_2","first-page":"56103","article-title":"Stereological estimation of dopaminergic neuron number in the mouse substantia nigra using the optical fractionator and standard microscopy equipment","volume":"1","author":"Ip CW","year":"2017","unstructured":"Ip CW, Cheong D, Volkmann J. Stereological estimation of dopaminergic neuron number in the mouse substantia nigra using the optical fractionator and standard microscopy equipment. J Vis Exp 2017; 1: 56103.","journal-title":"J Vis Exp"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1039\/C4MT00033A"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncb3066"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.8b00015"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1021\/acschembio.0c00716"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-014-0294-x"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.baga.2015.06.001"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2015.12.052"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-81147-1_4"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2008.01.046"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12868-017-0341-8"},{"key":"e_1_3_3_54_2","first-page":"2076942","article-title":"Cognition deficits in Parkinson\u2019s disease: mechanisms and treatment","volume":"2020","author":"Fang C","year":"2020","unstructured":"Fang C, Lv L, Mao S, et al. Cognition deficits in Parkinson\u2019s disease: mechanisms and treatment. Parkinsons Dis 2020; 2020: 2076942.","journal-title":"Parkinsons Dis"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2013.3"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.049192"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12868-021-00687-4"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2004.6.3\/galexander"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-009-0538-8"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2012.11.020"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3002566"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2990.1998.00115.x"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-011-0815-1"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.104525"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awab242"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2109617119"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2012.03.001"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.2c00057"},{"key":"e_1_3_3_69_2","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.11083"},{"key":"e_1_3_3_70_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16984-1"},{"key":"e_1_3_3_71_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1205748109"},{"key":"e_1_3_3_72_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1227157"},{"key":"e_1_3_3_73_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05835-8"},{"key":"e_1_3_3_74_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02824-8"},{"key":"e_1_3_3_75_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3080-04.2004"},{"key":"e_1_3_3_76_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awx221"},{"key":"e_1_3_3_77_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-021-02381-5"},{"key":"e_1_3_3_78_2","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.22611"},{"key":"e_1_3_3_79_2","unstructured":"Michael J. Fox Foundation. MJFF Alpha-synuclein mouse comparison study. https:\/\/www.michaeljfox.org\/sites\/default\/files\/media\/document\/Data%20for%20Webpage%20aSyn%20Mice%202023.pdf (2023)."},{"key":"e_1_3_3_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2013.09.004"},{"key":"e_1_3_3_81_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awad150"},{"key":"e_1_3_3_82_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awu057"},{"key":"e_1_3_3_83_2","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.213231"},{"key":"e_1_3_3_84_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-020-0616-4"},{"key":"e_1_3_3_85_2","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.265225"},{"key":"e_1_3_3_86_2","doi-asserted-by":"publisher","DOI":"10.1021\/acschemneuro.3c00247"},{"key":"e_1_3_3_87_2","doi-asserted-by":"publisher","DOI":"10.1002\/alz.040558"},{"key":"e_1_3_3_88_2","unstructured":"Alzheimer Research Forum. Drugs in Clinical Trial: ASN121151. https:\/\/www.alzforum.org\/therapeutics\/asn51 (2024 accessed 16 February 2025)."}],"container-title":["Journal of Parkinson\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1877718X251410291","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1877718X251410291","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1877718X251410291","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:51:28Z","timestamp":1790254288000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1877718X251410291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":87,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1177\/1877718X251410291"],"URL":"https:\/\/doi.org\/10.1177\/1877718x251410291","relation":{},"ISSN":["1877-7171","1877-718X"],"issn-type":[{"value":"1877-7171","type":"print"},{"value":"1877-718X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,10]]}}}